Source: Molecular Genetics and Metabolism. Unidade: FMRP
Subjects: ENZIMAS, DOENÇAS GENÉTICAS, ÍNDICE DE MASSA CORPORAL, CRIANÇAS EM IDADE PRÉ-ESCOLAR, HEMOGLOBINAS, CONTAGEM DE PLAQUETAS, BAÇO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WEINREB, Neal et al. Gaucher disease type 1 patients from the ICGG Gaucher Registry sustain initial clinical improvements during twenty years of imiglucerase treatment. Molecular Genetics and Metabolism, v. 132, n. 2, p. 100-111, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.ymgme.2020.12.295. Acesso em: 12 jun. 2024.APA
Weinreb, N., Camelo Júnior, J. S., Charrow, J., McClain, M. R., Mistry, P., & Belmatoug, N. (2021). Gaucher disease type 1 patients from the ICGG Gaucher Registry sustain initial clinical improvements during twenty years of imiglucerase treatment. Molecular Genetics and Metabolism, 132( 2), 100-111. doi:10.1016/j.ymgme.2020.12.295NLM
Weinreb N, Camelo Júnior JS, Charrow J, McClain MR, Mistry P, Belmatoug N. Gaucher disease type 1 patients from the ICGG Gaucher Registry sustain initial clinical improvements during twenty years of imiglucerase treatment [Internet]. Molecular Genetics and Metabolism. 2021 ; 132( 2): 100-111.[citado 2024 jun. 12 ] Available from: https://doi.org/10.1016/j.ymgme.2020.12.295Vancouver
Weinreb N, Camelo Júnior JS, Charrow J, McClain MR, Mistry P, Belmatoug N. Gaucher disease type 1 patients from the ICGG Gaucher Registry sustain initial clinical improvements during twenty years of imiglucerase treatment [Internet]. Molecular Genetics and Metabolism. 2021 ; 132( 2): 100-111.[citado 2024 jun. 12 ] Available from: https://doi.org/10.1016/j.ymgme.2020.12.295
